ClinicalTrials.gg
RecruitingNCT07576075Updated May 8, 2026

Volar Locking Plate Comparison With External Fixator

An interventional study of Volar locking plates and External Fixator in Articular Fracture, sponsored by Muhammad Aamir Latif. Recruiting at 1 site in Pakistan. Open to participants aged 20 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-05-08.

Sponsored by Muhammad Aamir Latif · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2026, 4 months ago, but the record still lists the study as recruiting.
  • Registered 6 months after the study started (first participant enrolled Oct 2025, registered May 2026).
  • Started Oct 2025; still recruiting 1 year 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
20 Years to 60 Years
Sex
All
01

Study summary

Local data has shown conflicting results regarding the outcomes of volar locking plates versus external fixators in distal intra-articular radius fractures. Therefore, the current study was planned with the objective of comparing the outcome of a volar locking plate versus an external fixator in distal intra-articular radius fractures.

Read the detailed description

Determining which method provides superior early functional recovery through this study would be beneficial for generating local data. Understanding and applying improved anatomical reduction techniques and achieving lower complication rates would enable these individuals to mobilize and return to their daily lives more quickly, ultimately enhancing their quality of life.

02

Conditions studied

  • Articular Fracture
03

In context

Lead sponsor

Muhammad Aamir Latif is the lead sponsor of 59 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Any gender
  • Aged 20 to 60
  • with intra-articular fractures of the distal radius
  • The fracture lasted less than seven days

Exclusion criteria

Exclusion Criteria:

  • Patients with bilateral distal radius fractures and any further related injuries or fractures
  • Distal radius open fractures
  • Individuals receiving , chemotherapeutic, or medications (based on medical history and records)
  • Individuals with underlying medical co-morbidities, such as diabetes and uncontrolled hypertension, (determined by their medical history and record)
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Group-A

    Patients will be treated with volar locking plates. The distal radius fragments will be stabilized using the conventional modified Henry's volar technique with 2.4 mm locking compression plates.

    Procedure: Volar locking plates

  • Experimental
    Group-B

    Patients will be employed with an external fixator, directly fixing to the second or third metacarpal bone using 3-mm pins and the radius using 4-mm Schanz pins.

    Procedure: External Fixator

Interventions

  • ProcedureVolar locking plates

    Patients will be treated with volar locking plates. The distal radius fragments will be stabilized using the conventional modified Henry's volar technique with 2.4 mm locking compression plates.

  • ProcedureExternal Fixator

    Patients will be employed with an external fixator, directly fixing to the second or third metacarpal bone using 3-mm pins and the radius using 4-mm Schanz pins.

06

What researchers measure

Primary outcomes

  1. Operative time

    Operative time will be measured in minutes from skin incision to skin closure.

    Time frame: 2 hours

  2. Blood Loss

    Blood loss will be estimated in milliliters, measuring clots in a suction bottle, the difference between the pre- and postoperative sponge weights using the 1 g-1 ml formula, and blood clots in a clenched fist.

    Time frame: 3 hours

  3. Wrist function

    Wrist function will be evaluated using the Mayo Wrist Score. Patient frequencies will be recorded, with scores of 90-100 points reflecting an excellent outcome, 80-89 points indicating a good outcome, 60-79 points representing a satisfactory outcome, and scores below 60 points denoting a poor outcome.

    Time frame: 3 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — Data can be shared on a reasonable request.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Oct 2025 (actual). Primary completion is estimated for Jun 2026, 8 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
May 4, 2026
First posted
May 8, 2026
StartActual
Oct 5, 2025
Primary completionEst.
Jun 30, 2026
CompletionEst.
Jun 30, 2026
Last update
May 8, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07576075
Lead sponsor
Muhammad Aamir Latif
Responsible party
Muhammad Aamir Latif (Research Consultant, RESnTEC, Institute of Research) — Sponsor-investigator
First posted
May 8, 2026
Start date
Oct 5, 2025
Primary completion
Jun 30, 2026 (estimated)
Completion
Jun 30, 2026 (estimated)
Last update
May 8, 2026

Study contacts

Burhan Ulhaq
Contact
burhankhan224@gmail.com
+923326456246
Abdul-Munaf Saud, FCPS
Contact
drabdulmunafsaud@gmail.com
+923005111668
Burhan Ulhaq
principal investigator · Bahawal Victoria Hospital/Quid-e-Azam Medical College, Bahawalpur
Abdul-Munaf Saud, FCPS
study director · Bahawal Victoria Hospital/Quaid-e-Azam Medical College, Bahawalpur

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion